Biogen Inc. (BIIB) Financial Statements (2023 and earlier)
Company Profile
| Business Address |
225 BINNEY STREET CAMBRIDGE, MA 02142 |
| State of Incorp. | DE |
| Fiscal Year End | December 31 |
| Industry (SIC) | 2836 - Biological Products, Except Diagnostic Substances (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in millions)
| 6/30/2023 MRQ | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments | 5,112 | 1,541 | 1,906 | 2,914 | 1,225 | 3,689 | |||
| Cash and cash equivalents | 2,848 | 627 | 2,914 | 1,225 | 1,574 | ||||
| Short-term investments | 2,265 | 1,541 | 1,279 | 2,115 | |||||
| Receivables | 1,705 | 1,549 | 1,914 | 1,881 | 1,959 | 1,787 | |||
| Inventory, net of allowances, customer advances and progress billings | 1,344 | 1,352 | 1,069 | 804 | 930 | 903 | |||
| Inventory | 1,344 | 1,352 | 1,069 | 804 | 930 | 903 | |||
| Prepaid expense | 271 | ||||||||
| Other current assets | 1,418 | 741 | 881 | 631 | 688 | 962 | |||
| Other undisclosed current assets | 212 | 2,674 | 1,118 | 2,152 | 2,569 | 533 | |||
| Total current assets: | 9,791 | 7,857 | 6,887 | 8,382 | 7,641 | 7,873 | |||
| Noncurrent Assets | |||||||||
| Inventory, Noncurrent | 7 | ||||||||
| Operating lease, right-of-use asset | 404 | 375 | 433 | 427 | ✕ | ✕ | |||
| Property, plant and equipment | 3,299 | 3,416 | 3,412 | 3,247 | 3,601 | 3,182 | |||
| Long-term investments and receivables | 706 | 892 | 772 | 3,057 | |||||
| Long-term investments | 706 | 892 | 772 | 3,057 | |||||
| Intangible assets, net (including goodwill) | 7,599 | 7,982 | 8,846 | 9,285 | 8,826 | 8,512 | |||
| Goodwill | 5,749 | 5,761 | 5,762 | 5,758 | 5,706 | 4,633 | |||
| Intangible assets, net (excluding goodwill) | 1,850 | 2,221 | 3,084 | 3,527 | 3,120 | 3,880 | |||
| Deferred income tax assets | 1,226 | 1,415 | 1,370 | ✕ | ✕ | ||||
| Other noncurrent assets | 1,529 | 1,940 | 2,899 | 1,253 | 1,691 | 1,028 | |||
| Deferred tax assets, net | ✕ | ✕ | ✕ | ✕ | ✕ | 2,154 | |||
| Other undisclosed noncurrent assets | 4,640 | 1,369 | |||||||
| Total noncurrent assets: | 14,763 | 16,021 | 17,732 | 18,853 | 17,648 | 15,779 | |||
| TOTAL ASSETS: | 24,554 | 23,877 | 24,619 | 27,234 | 25,289 | 23,653 | |||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities | 751 | 764 | 597 | 602 | 434 | 464 | |||
| Taxes payable | ✕ | ✕ | 175 | 142 | 71 | 64 | 68 | ||
| Accounts payable | 492 | 589 | 455 | 531 | 371 | 396 | |||
| Accrued liabilities | 260 | ||||||||
| Debt | 999 | 1,496 | 3 | ||||||
| Other liabilities | 2,521 | 2,535 | 3,145 | 2,766 | 2,861 | 2,901 | |||
| Total current liabilities: | 3,273 | 4,298 | 3,742 | 4,864 | 3,295 | 3,368 | |||
| Noncurrent Liabilities | |||||||||
| Long-term debt and lease obligation | 6,567 | 330 | 402 | 6,413 | |||||
| Long-term debt, excluding current maturities | 6,567 | 6,000 | |||||||
| Liabilities, other than long-term debt | 1,612 | 2,015 | 2,362 | 2,152 | 3,026 | 1,751 | |||
| Accounts payable and accrued liabilities | 803 | ||||||||
| Deferred tax liabilities, net | ✕ | ✕ | ✕ | ✕ | ✕ | 1,636 | 123 | ||
| Deferred income tax liabilities | 335 | 695 | 1,033 | ✕ | ✕ | ||||
| Other liabilities | 944 | 1,321 | 1,330 | 1,349 | 1,389 | 1,629 | |||
| Operating lease, liability | 333 | 330 | 402 | 413 | ✕ | ✕ | |||
| Other undisclosed noncurrent liabilities | (286) | 6,274 | 7,426 | 467 | 5,937 | 5,935 | |||
| Total noncurrent liabilities: | 7,893 | 8,619 | 10,191 | 9,031 | 8,962 | 7,686 | |||
| Total liabilities: | 11,166 | 12,918 | 13,933 | 13,895 | 12,257 | 11,055 | |||
| Equity | |||||||||
| Equity, attributable to parent | 13,398 | 10,896 | 10,700 | 13,343 | 13,040 | 12,613 | |||
| Common stock | 0 | 0 | 0 | 0 | 0 | 0 | |||
| Treasury stock, value | (2,977) | (2,977) | (2,977) | (2,977) | (2,977) | (2,977) | |||
| Additional paid in capital | 73 | 68 | 98 | ||||||
| Accumulated other comprehensive loss | (165) | (107) | (299) | (135) | (240) | (318) | |||
| Retained earnings | 16,467 | 13,912 | 13,976 | 16,455 | 16,257 | 15,810 | |||
| Equity, attributable to noncontrolling interest | (10) | 64 | (14) | (4) | (8) | (15) | |||
| Total equity: | 13,388 | 10,960 | 10,686 | 13,339 | 13,032 | 12,598 | |||
| TOTAL LIABILITIES AND EQUITY: | 24,554 | 23,877 | 24,619 | 27,234 | 25,289 | 23,653 | |||
Income Statement (P&L) ($ in millions)
| 6/30/2023 TTM | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | ||
|---|---|---|---|---|---|---|---|---|
| Revenues | 10,173 | 10,982 | 13,445 | 14,378 | 13,453 | 12,274 | ||
| Revenue, net | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ | 10,715 | |
| Cost of revenue | (2,320) | (2,948) | (2,417) | (2,623) | (2,736) | (1,805) | ||
| Cost of goods and services sold | (2,278) | (2,110) | (1,805) | (1,955) | (1,816) | (1,707) | ||
| Other undisclosed gross profit | 611 | 668 | 920 | 175 | ||||
| Gross profit: | 7,854 | 8,034 | 11,639 | 12,423 | 11,637 | 10,644 | ||
| Operating expenses | (4,262) | (5,194) | (6,478) | (4,712) | (4,828) | (5,125) | ||
| Other operating income, net (Other undisclosed Other operating income, net) | ||||||||
| Other undisclosed operating loss | (611) | (668) | (920) | (175) | ||||
| Operating income: | 3,592 | 2,841 | 4,550 | 7,043 | 5,889 | 5,344 | ||
| Nonoperating income (expense) | 108 | (1,096) | 497 | 83 | 11 | (215) | ||
| Investment income, nonoperating | 1,595 | 11 | 42 | 120 | 113 | 79 | ||
| Gain (loss), foreign currency transaction, before tax | 36 | (22) | (11) | (7) | (10) | 6 | ||
| Other nonoperating income (expense) | 10 | (6) | 3 | (47) | (11) | (13) | ||
| Interest and debt expense | (247) | (254) | (223) | (187) | (201) | (251) | ||
| Other undisclosed income from continuing operations before equity method investments, income taxes | 138 | 254 | 223 | 187 | 201 | 251 | ||
| Income from continuing operations before equity method investments, income taxes: | 3,592 | 1,745 | 5,048 | 7,126 | 5,900 | 5,129 | ||
| Income (loss) from equity method investments | 3 | 35 | 3 | (79) | ||||
| Income from continuing operations before income taxes: | 3,594 | 1,780 | 5,051 | 7,047 | 5,900 | 5,129 | ||
| Income tax expense | (633) | (53) | (992) | (1,158) | (1,426) | (2,459) | ||
| Income from continuing operations: | 2,962 | 1,728 | 4,059 | 5,889 | 4,474 | 2,670 | ||
| Income before gain (loss) on sale of properties: | ✕ | 1,728 | 4,059 | 5,889 | 4,474 | 2,670 | ||
| Other undisclosed net income | 2 | |||||||
| Net income: | 2,962 | 1,728 | 4,061 | 5,889 | 4,474 | 2,670 | ||
| Net income (loss) attributable to noncontrolling interest | 85 | (172) | (60) | (43) | (131) | |||
| Net income available to common stockholders, diluted: | 3,047 | 1,556 | 4,001 | 5,889 | 4,431 | 2,539 | ||
Comprehensive Income ($ in millions)
| 6/30/2023 TTM | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | ||
|---|---|---|---|---|---|---|---|---|
| Net income: | 2,962 | 1,728 | 4,061 | 5,889 | 4,474 | 2,670 | ||
| Other comprehensive income (loss) | (58) | 193 | (163) | 105 | 76 | (2) | ||
| Other undisclosed comprehensive income | 3 | |||||||
| Comprehensive income: | 2,903 | 1,921 | 3,898 | 5,993 | 4,550 | 2,672 | ||
| Comprehensive income (loss), net of tax, attributable to noncontrolling interest | 85 | (172) | (61) | 0 | (43) | 131 | ||
| Other undisclosed comprehensive loss, net of tax, attributable to parent | (262) | |||||||
| Comprehensive income, net of tax, attributable to parent: | 2,989 | 1,748 | 3,837 | 5,994 | 4,507 | 2,541 | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.